Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference, Conference Call, Webcast, Advisory

bluebird bio Announces First Quarter 2023 Earnings Date and Upcoming Investor Events


bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Company's first quarter financial results, including commercial, regulatory and operational updates, will be released pre-market on Tuesday, May 9.

In addition, members of the management team will participate in the following upcoming investor conferences:

To access the live webcasts of bluebird bio's presentations, please visit the "Events & Presentations" page within the Investors & Media section of the bluebird bio website at http://investor.bluebirdbio.com. Replays of the webcasts will be available on the bluebird bio website for 90 days following the events.

About bluebird bio, Inc.
bluebird bio is pursuing curative gene therapies to give patients and their families more bluebird days.

With a dedicated focus on severe genetic diseases, bluebird has industry-leading programs for sickle cell disease, ?-thalassemia and cerebral adrenoleukodystrophy and is advancing research to apply new technologies to these and other diseases. We custom design each of our therapies to address the underlying cause of disease and have developed in-depth and effective analytical methods to understand the safety of our lentiviral vector technologies and drive the field of gene therapy forward.

Founded in 2010, bluebird has the largest and deepest ex-vivo gene therapy data set in the world?setting the standard for the industry. Today, bluebird continues to forge new paths, combining our real-world experience with a deep commitment to patient communities and a people-centric culture that attracts and grows a diverse flock of dedicated birds.

For more information, visit bluebirdbio.com or follow us on social media at @bluebirdbio, LinkedIn, Instagram and YouTube.

bluebird bio is a trademark of bluebird bio, Inc.


These press releases may also interest you

at 12:05
Transaction in Own Shares
Transaction in Own Shares 4 July, 2024 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Shell plc (the ?Company') announces that on 4 July, 2024 it purchased the following number of Shares for cancellation. Aggregated information on Shares purchased according to...

at 12:04
Canadian Investment Regulatory Organization Trade Resumption - VGCX
Trading resumes in: Company: Victoria Gold Corp. TSX Symbol: VGCX All Issues: Yes Resumption (ET): 12:15 PM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...

at 12:00
USO and John Deere Join Forces To Support Those Who Serve
John Deere has made a two-year, $100,000 commitment to USO, the leading nonprofit dedicated to strengthening the wellbeing of America's military members and their families. This donation will enable John Deere employees and customers to show their...

at 11:46
MAGNETIC NORTH ACQUISITION CORP. PROVIDES BI-WEEKLY UPDATE ?ON STATUS OF MANAGEMENT CEASE TRADE ORDER ?
Magnetic North Acquisition Corp.  ("Magnetic North" or the "Company") is providing this bi-weekly update on the status of the management cease trade order granted on May 7, 2024 (the "MCTO") by its principal regulator, the Alberta Securities...

at 11:25
CSL Highlights Major ESG Achievements in 2023 Sustainability Report
The CSL Group ("CSL"), a global leader in sustainable marine transportation solutions, today unveiled its 2023 Corporate Sustainability Report, reflecting its commitment to transparency and accountability in environmental, social, and governance...

at 11:24
Canadian Investment Regulatory Organization Trade Resumption - GXU
Trading resumes in: Company: GoviEx Uranium Inc. TSX-Venture Symbol: GXU All Issues: Yes Resumption (ET): 11:30 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts...

More news about Business...


News published on and distributed by: